Palliative care opportunities for women with advanced ovarian cancer associated with intraperitoneal chemotherapy

Shirley Otis-Green, Mark T. Wakabayashi, Robert Morgan, Amy Hakim, Betty Ferrell, Virginia Sun, Eunice Yang, Marcia Grant

Research output: Contribution to journalArticle

Abstract

Intraperitoneal chemotherapy poses both potential benefits as a cancer treatment and negative consequences on patient and family quality of life. The profound multi-dimensional quality of life impact of intraperitoneal (IP) chemotherapy upon women with advanced ovarian cancer makes the early integration of palliative care particularly important for this population. Numerous opportunities occur throughout the treatment process to improve the delivery of biopsychosocial-spiritual support to women receiving IP chemotherapy.

Original languageEnglish (US)
Pages (from-to)44-53
Number of pages10
JournalJournal of palliative medicine
Volume16
Issue number1
DOIs
StatePublished - Jan 1 2013

    Fingerprint

ASJC Scopus subject areas

  • Nursing(all)
  • Anesthesiology and Pain Medicine

Cite this

Otis-Green, S., Wakabayashi, M. T., Morgan, R., Hakim, A., Ferrell, B., Sun, V., Yang, E., & Grant, M. (2013). Palliative care opportunities for women with advanced ovarian cancer associated with intraperitoneal chemotherapy. Journal of palliative medicine, 16(1), 44-53. https://doi.org/10.1089/jpm.2012.0174